TY - CHAP M1 - Book, Section TI - Salvage Surgery for Recurrent Esophageal Cancer A1 - Li, Zhigang A1 - Rice, Thomas W. A2 - Sugarbaker, David J. A2 - Bueno, Raphael A2 - Colson, Yolonda L. A2 - Jaklitsch, Michael T. A2 - Krasna, Mark J. A2 - Mentzer, Steven J. A2 - Williams, Marcia A2 - Adams, Ann Y1 - 2015 N1 - T2 - Adult Chest Surgery, 2e AB - Recurrent (after a disease-free period) or persistent esophageal cancer following definitive therapy, particularly for locally advanced cancer, is common. Treatment failure following definitive chemoradiotherapy in RTOG-8501 was 46% at a minimum of 5 years follow-up.1 Twenty percent of patients had recurrence after clinical complete response and 26% persistent cancer. In RTOG-8911 following R0 esophagectomy, at a median follow-up of 8.8 years, cancer recurrence was reported in 52% of patients receiving induction chemotherapy and 56% of patients with esophagectomy alone.2 SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accesssurgery.mhmedical.com/content.aspx?aid=1105839260 ER -